Home > Insider Trading > Filing (0000899243-20-011549)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1629137	Global Blood Therapeutics Inc.	GBT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1188919	W Ted Love	C/O Global Blood Therapeutics, Inc. 181 Oyster Point Boulevard South San Francisco CA 94080	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-04-27	1,300	$81.15	1,076,150	No	4	S	Direct
Common Stock	Disposition	2020-04-27	1,517	$80.63	1,074,633	No	4	S	Direct
Common Stock	Disposition	2020-04-28	40,000	$80.00	1,034,633	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,500	Indirect	By Daughter
Common Stock	2,500	Indirect	By Daughter

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $81.02 to $81.24 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Represents the weighted average sale price of the shares sold ranging from $80.00 to $80.90 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Represents the weighted average sale price of the shares sold ranging from $80.00 to $80.05 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.